Currently BC classification relies on the detection of four biomarkers: estrogen receptor (ER), progesterone receptors (PgR), human epidermal growth factor receptor 2 (HER2), and the proliferation index (Ki67 staining). This evidence concerns the gene ESR1 and breast cancer.